Literature DB >> 19858696

Wide excision or Mohs micrographic surgery for the treatment of primary dermatofibrosarcoma protuberans.

Ari-Nareg Meguerditchian1, Jiping Wang, Bethany Lema, William G Kraybill, Nathalie C Zeitouni, John M Kane.   

Abstract

OBJECTIVES: Dermatofibrosarcoma protuberans (DFSP) is a spindle cell tumor with a high local recurrence rate. Wide excision (WE) has been the standard treatment, but ideal margin width is poorly defined and Mohs micrographic surgery (MMS) has emerged as an alternative procedure. This study examines the use of WE versus MMS for the treatment of primary DFSP at a single institution.
METHODS: Retrospective review of 48 primary DFSP cases treated from 1971 to 2006. Patient demographics, tumor features, surgical modality (WE vs. MMS), final pathology, and clinical outcome were evaluated.
RESULTS: Twenty-eight patients underwent WE versus 20 patients for MMS. Median age was 40 years. Median WE margin width was 2 cm. For MMS, the median number of layers required to clear the tumor was 2. Median maximal defect size was 10 cm for WE versus 9.4 cm for MMS. Advanced closure techniques were required for 18% WE versus 65% MMS (P = 0.001). Median operative time was significantly lower for WE at 77 minutes versus 257 minutes for MMS (P < 0.001). Positive margins were present in 21.4% (6/28) WE versus 0% MMS (P = 0.01). At a median follow-up of 49.9 months for WE and 40.4 months for MMS, local recurrence rates were 3.6% (1/28) and 0%, respectively (P = 1.0).
CONCLUSIONS: From a surgical standpoint, WE was faster than MMS and resulted in a less complex defect/closure. Although positive margin resection was more common with WE, local control was ultimately similar for the 2 surgical modalities. The choice of WE versus MMS should be based on individualized patients/tumor characteristics and institutional expertise in these modalities.

Entities:  

Mesh:

Year:  2010        PMID: 19858696     DOI: 10.1097/COC.0b013e3181aaca87

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  19 in total

1.  Dermatofibrosarcoma protuberans of the breast: A case study.

Authors:  Dionysios Dimas; Ioannis Boutas; Anastasios Potiris; Nektarios Koufopoulos; Dimitrios Balalis; Kyparissia Sitara; Fotios Danglis; Ioannis Misitzis
Journal:  Mol Clin Oncol       Date:  2021-01-20

Review 2.  Dermatofibrosarcoma Protuberans.

Authors:  Alvaro E Acosta; Catalina Santa Vélez
Journal:  Curr Treat Options Oncol       Date:  2017-08-10

Review 3.  A Review of the Global Guidelines on Surgical Margins for Nonmelanoma Skin Cancers.

Authors:  Amanda F Nahhas; Chase A Scarbrough; Shannon Trotter
Journal:  J Clin Aesthet Dermatol       Date:  2017-04

4.  Soft tissue tumors of the anorectum: rare, complex and misunderstood.

Authors:  Mohammed O Nassif; Nora H Trabulsi; Kelli M Bullard Dunn; Ayoub Nahal; Ari-Nareg Meguerditchian
Journal:  J Gastrointest Oncol       Date:  2013-03

5.  Advances in molecular characterization and targeted therapy in dermatofibrosarcoma protuberans.

Authors:  Piotr Rutkowski; Agnieszka Wozniak; Tomasz Switaj
Journal:  Sarcoma       Date:  2011-03-30

6.  Surgical Treatment of Enormous Recurrent Dermatofibrosarcoma Protuberans.

Authors:  Shijie Xing; Jianjun Wang; Wei Zhai; Tian Xia; Chuanxiao Wang
Journal:  Thorac Cardiovasc Surg Rep       Date:  2015-03-30

7.  Neoadjuvant treatment of Dermatofibrosarcoma Protuberans of pancreas with Imatinib: case report and systematic review of literature.

Authors:  Mashaal Dhir; David G Crockett; Todd M Stevens; Peter T Silberstein; William J Hunter; Jason M Foster
Journal:  Clin Sarcoma Res       Date:  2014-08-06

8.  A malignant neoplasm imitating a subcutaneous cyst.

Authors:  Daisuke Maeda; Kyosuke Minami; Yoko Osaki; Hideaki Miwa; Ko Hosokawa; Tateki Kubo
Journal:  Eplasty       Date:  2012-07-20

Review 9.  Cutaneous soft tissue sarcomas: survival-related factors.

Authors:  Areti Gkantaifi; Alexandros Diamantis; Davide Mauri; Ioanna Nixon; Anastassios Kyriazoglou; Ioannis Baloyiannis; Nikolaos Tsoukalas; Nikolaos Charalampakis; Dimitrios Schizas; Francesco Cuccia; Filippo Alongi; Ramon Andrade de Mello; George Iliadis; Konstantinos Kamposioras; Michalis Mazonakis; Maria Tolia
Journal:  Arch Dermatol Res       Date:  2021-07-17       Impact factor: 3.033

10.  Fibrosarcomatous dermatofibrosarcoma protuberans: an unusual tumor in the facial skin.

Authors:  Arvind Krishnamurthy; Urmila Majhi
Journal:  Indian J Dermatol       Date:  2014-01       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.